Related Experiment Video
Updated: Jul 27, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
467
[Update on papillary thyroid cancer-What is relevant for surgeons?]
Ann-Kathrin Lederer1, Thomas J Musholt2
1Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Langenbeckstraße 1, 55131, Mainz, Deutschland.
Chirurgie (Heidelberg, Germany)
|April 2, 2025
Summary
Papillary thyroid cancer (PTC), Germany's most common thyroid tumor, is diagnosed via histology. Early detection and surgical removal offer a >90% 10-year survival rate, but variants impact recurrence risk.
Area of Science:
- Oncology
- Pathology
- Endocrinology
Context:
- Papillary thyroid cancer (PTC) is the most prevalent malignant thyroid neoplasm in Germany.
- Accurate diagnosis relies on histological examination of suspicious thyroid tissue.
- Preoperative diagnosis is supported by clinical signs, ultrasound, and fine-needle aspiration, potentially with molecular analysis.
Purpose:
- To provide a comprehensive overview of current knowledge regarding the diagnosis, treatment, and prognosis of papillary thyroid cancer.
- To discuss the implications of PTC variants on treatment strategies and patient outcomes.
- To address the ongoing debate surrounding the extent of surgical intervention for PTC.
Summary:
- PTC diagnosis is confirmed histologically, with clinical and molecular tools aiding preoperative suspicion.
- Early diagnosis and complete surgical resection lead to a favorable prognosis (>90% 10-year survival).
- Histological variants of PTC influence metastatic potential and recurrence risk, necessitating tailored treatment approaches.
Impact:
- Informing clinical decision-making for PTC diagnosis and management.
- Highlighting the importance of considering PTC variants in treatment planning.
- Contributing to the ongoing discussion on optimizing surgical interventions for PTC.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...